No Data
No Data
Daito Pharmaceutical: Confirmation letter
Daito Pharmaceutical: Securities Report - 82nd Fiscal Year (2023/06/01 - 2024/05/31)
Daito Pharmaceutical: Extraordinary Report
KHC, Taiping Electric, etc. (Part 1)
<1451> KHC Corporation SOLABLE Shareholding Ratio 53.49% -> 53.23% Reporting Obligation Date 2024/08/15 <1968> Taihei Denko Co., Ltd Mitsui Sumitomo DS Asset Management Co., Ltd. Shareholding Ratio - -> 5.03% Reporting Obligation Date 2024/08/15 <2134> Kitahama Capital Partners Co., Ltd. SUN ORGANIC FARM Co., Ltd. Shareholding Ratio 73
Analysts Offer Insights on Real Estate Companies: Daito Construction (OtherDITTF) and Kerry Properties (OtherKRYPF)
Kaname Capital increases its stake in Daito Pharmaceutical(4577.JP) to 9.98%
On Aug 22, Kaname Capital submitted the Change Report to Ministry of Finance. The report shows that Kaname Capital increased their holdings in $Daito Pharmaceutical(4577.JP)$, with their joint
No Data